Emil N.

Emil N. is an experienced professional in the fields of pricing, value, and access strategy, with a robust background in business development and cross-departmental leadership. Currently serving as Principal at Arthur D. Little, Emil has held key leadership roles at various organizations, including DentalAce as CEO and Board Member, and The Dedham Group as Director of Global Market Access. Noteworthy achievements include successfully negotiating significant funding rounds, spearheading multiple high-value projects for top BioPharma clients, and advancing corporate fundraising efforts at Verana Health. Emil’s previous experience encompasses roles at Gilead Sciences, Deloitte, and Avalere Health, where strategic pricing and market access were pivotal. Emil holds an MBA from Columbia Business School and a BBA in Finance and International Business from The George Washington University.